This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Bio-Techne Corp. slid 4.0% to $69.92 on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.7% to 6,066.44 and the Dow Jones Industrial Average rising 0.4% to 44,470.41.
This was the stock's third consecutive day of losses.
Bio-Techne Corp. closed 18.3% below its 52-week high of $85.57, which the company achieved on May 15th.
The stock underperformed when compared to some of its competitors, as Amgen Inc. rose 0.4% to $294.79, Charles River Laboratories International Inc. fell 2.4% to $159.89, and BioMarin Pharmaceutical Inc. fell 0.67% to $63.50.
Trading volume totaled 2.9 million, compared to the 50-day average of 934,927.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
February 10, 2025 16:42 ET (21:42 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。